What is a stock summary page? Click here for an overview.
Business Description
AK Medical Holdings Ltd
ISIN : KYG020141019
Compare
Compare
Traded in other countries / regions
01789.Hong Kong Index Membership
Hong Kong Stock ConnectiShares MSCI ACWI Ex US Index Fund IPO Date
2017-12-20Description
AK Medical Holdings Ltd is an investment holding company which designs, develops, produces, and markets orthopedic joint implants and related products. The company's geographical segments include China and the United Kingdom. It derives the majority of revenue from China. The company offers off-the-shelf products, such as knee replacement and hip replacement implants; and 3D-printed products, including 3D-printed hip replacement implants, spinal interbody cages, and artificial vertebral bodies.
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 10.39 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | 0.33 | |||||
Interest Coverage | 449.77 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 7.77 | |||||
Beneish M-Score | -2.16 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.2 | |||||
3-Year EBITDA Growth Rate | -12.3 | |||||
3-Year EPS without NRI Growth Rate | -19.1 | |||||
3-Year Book Growth Rate | 2.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 33.29 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 22.88 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 41.33 | |||||
9-Day RSI | 48.48 | |||||
14-Day RSI | 51.73 | |||||
3-1 Month Momentum % | 22.43 | |||||
6-1 Month Momentum % | 11.46 | |||||
12-1 Month Momentum % | -3.43 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.65 | |||||
Quick Ratio | 2.83 | |||||
Cash Ratio | 1.73 | |||||
Days Inventory | 383.43 | |||||
Days Sales Outstanding | 133.35 | |||||
Days Payable | 106.12 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.77 | |||||
Dividend Payout Ratio | 0.18 | |||||
3-Year Dividend Growth Rate | -9 | |||||
Forward Dividend Yield % | 1.23 | |||||
5-Year Yield-on-Cost % | 0.88 | |||||
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | 0.2 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 60.03 | |||||
Operating Margin % | 22.34 | |||||
Net Margin % | 20.35 | |||||
FCF Margin % | -3.57 | |||||
ROE % | 10.86 | |||||
ROA % | 8.59 | |||||
ROIC % | 12.05 | |||||
3-Year ROIIC % | -32.1 | |||||
ROC (Joel Greenblatt) % | 24.81 | |||||
ROCE % | 11.43 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 22.76 | |||||
Forward PE Ratio | 17.78 | |||||
PE Ratio without NRI | 22.76 | |||||
Shiller PE Ratio | 34.41 | |||||
PEG Ratio | 10.84 | |||||
PS Ratio | 4.52 | |||||
PB Ratio | 2.32 | |||||
Price-to-Tangible-Book | 2.5 | |||||
Price-to-Operating-Cash-Flow | 52.25 | |||||
EV-to-EBIT | 17.9 | |||||
EV-to-Forward-EBIT | 11.8 | |||||
EV-to-EBITDA | 17.9 | |||||
EV-to-Revenue | 4 | |||||
EV-to-Forward-Revenue | 2.64 | |||||
EV-to-FCF | -108.69 | |||||
Price-to-GF-Value | 0.58 | |||||
Price-to-Projected-FCF | 2.35 | |||||
Price-to-Graham-Number | 1.59 | |||||
Price-to-Net-Current-Asset-Value | 4.12 | |||||
Price-to-Net-Cash | 18.28 | |||||
Earnings Yield (Greenblatt) % | 5.59 | |||||
FCF Yield % | -0.79 | |||||
Forward Rate of Return (Yacktman) % | 2.93 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AK Medical Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 1,443.319 | ||
EPS (TTM) (HK$) | 0.257 | ||
Beta | 0.39 | ||
3-Year Sharpe Ratio | 0.34 | ||
3-Year Sortino Ratio | 0.5 | ||
Volatility % | 47.11 | ||
14-Day RSI | 51.73 | ||
14-Day ATR (HK$) | 0.320074 | ||
20-Day SMA (HK$) | 5.9415 | ||
12-1 Month Momentum % | -3.43 | ||
52-Week Range (HK$) | 3.49 - 6.46 | ||
Shares Outstanding (Mil) | 1,116.3 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
AK Medical Holdings Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
AK Medical Holdings Ltd Stock Events
Event | Date | Price (HK$) | ||
---|---|---|---|---|
No Event Data |
AK Medical Holdings Ltd Frequently Asked Questions
What is AK Medical Holdings Ltd(HKSE:01789)'s stock price today?
The current price of HKSE:01789 is HK$5.85. The 52 week high of HKSE:01789 is HK$6.46 and 52 week low is HK$3.49.
When is next earnings date of AK Medical Holdings Ltd(HKSE:01789)?
The next earnings date of AK Medical Holdings Ltd(HKSE:01789) is .
Does AK Medical Holdings Ltd(HKSE:01789) pay dividends? If so, how much?
The Dividend Yield %  of AK Medical Holdings Ltd(HKSE:01789) is 0.77% (As of Today), Highest Dividend Payout Ratio of AK Medical Holdings Ltd(HKSE:01789) was 0.42. The lowest was 0.12. And the median was 0.23. The  Forward Dividend Yield % of AK Medical Holdings Ltd(HKSE:01789) is 1.23%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |